(Q40588204)

21 September 2017

title

Inhibition of herpes simplex virus infection by lactoferrin is dependent on interference with the virus binding to glycosaminoglycans (English)

1 reference

21 September 2017

2

1 reference

21 September 2017

5

1 reference

21 September 2017

Fabiana Superti

3

0 references

Maria E Johansson

series ordinal

4

object named as

Maria Johansson

1 reference

21 September 2017

Magda Marchetti

1

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

21 September 2017

1 reference

21 September 2017

volume

318

1 reference

21 September 2017

issue

1

1 reference

21 September 2017

page(s)

405-413

1 reference

Lactoferrin and lactoferricin inhibit Herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir.

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.029

Evidence for an interaction of herpes simplex virus with chondroitin sulfate proteoglycans during infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.029

Neurovirulence of herpes simplex virus types 1 and 2 isolates in diseases of the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.029

Role of heparan sulphate proteoglycans in the regulation of human lactoferrin binding and activity in the MDA-MB-231 breast cancer cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.029

Lactoferrin inhibits herpes simplex virus type-1 (HSV-1) infection to mouse cornea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.029

Differences in the role of glycoprotein C of HSV-1 and HSV-2 in viral binding may contribute to serotype differences in cell tropism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.029

Inhibition with lactoferrin of in vitro infection with human herpes virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.029

Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.029

Lactoferrin binding to heparan sulfate proteoglycans and the LDL receptor-related protein. Further evidence supporting the importance of direct binding of remnant lipoproteins to HSPG

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.029

Mode of interaction between platelet factor 4 and heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.029

Lactoferrin inhibits herpes simplex virus type 1 adsorption to Vero cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.029

Metal complexes of bovine lactoferrin inhibit in vitro replication of herpes simplex virus type 1 and 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.029

Herpes simplex virus type 1 glycoprotein C is necessary for efficient infection of chondroitin sulfate-expressing gro2C cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.029

The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.029

Three-dimensional structure of diferric bovine lactoferrin at 2.8 A resolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.029

Lactoferrin regulates the activity of heparin proteoglycan-bound mast cell chymase: characterization of the binding of heparin to lactoferrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.029

Properties of a heparin-binding peptide derived from bovine lactoferrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.029

Emerging views of heparan sulfate glycosaminoglycan structure/activity relationships modulating dynamic biological functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.029

A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.029

Limited variability of glycoprotein gene sequences and neutralizing targets in herpes simplex virus type 2 isolates and stability on passage in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.029

Localization of a functional site on herpes simplex virus type 1 glycoprotein C involved in binding to cell surface heparan sulphate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.029

Herpes simplex virus types 1 and 2 differ in their interaction with heparan sulfate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.029

Glycosaminoglycan-binding ability is a feature of wild-type strains of herpes simplex virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.029

N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.029

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.029

7 January 2021

Antiviral activities of lactoferrin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.029

Characterization of the glycosaminoglycan-binding region of lactoferrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.029

Herpes simplex virus infection and propagation in a mouse L cell mutant lacking heparan sulfate proteoglycans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.029

7 January 2021

Differences in the susceptibility of herpes simplex virus types 1 and 2 to modified heparin compounds suggest serotype differences in viral entry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.029

7 January 2021

Herpes simplex virus type 1 glycoprotein C-negative mutants exhibit multiple phenotypes, including secretion of truncated glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.029

7 January 2021

Initial interaction of herpes simplex virus with cells is binding to heparan sulfate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.029

7 January 2021

10.1016/J.VIROL.2003.09.029

Identifiers

DOI

1 reference

21 September 2017

1 reference